Version 2000: the new β-lactamases of Gram-negative bacteria at the dawn of the new millennium

Ahmad, 1999, Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae, Clin. Infect. Dis, 29, 352, 10.1086/520214 Ambler, 1980, The structure of beta-lactamases, Philos. Trans. Roy. Soc. Lond. B. Biol. Sci., 289, 321, 10.1098/rstb.1980.0049 Bush, 1995, A functional classification scheme for β-lactamases and its correlation with molecular structure, Antimicrob. Agents. Chemother., 39, 1211, 10.1128/AAC.39.6.1211 Bush, 1986, Methodology for the study of beta-lactamases, Antimicrob. Agents. Chemother., 30, 6, 10.1128/AAC.30.1.6 Bush, 1989, Characterization of β-lactamases, Antimicrob. Agents. Chemother., 33, 259, 10.1128/AAC.33.3.259 Livermore, 1998, β-lactamase-mediated resistance and opportunities for its control, J. Antimicrob. Chemother., 41, 25, 10.1093/jac/41.suppl_4.25 Massova, 1998, Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases, Antimicrob. Agents. Chemother., 42, 1, 10.1128/AAC.42.1.1 Knox, 1995, Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure, Antimicrob. Agents. Chemother., 39, 2593, 10.1128/AAC.39.12.2593 Ghuysen, 1991, Serine β-lactamases and penicillin-binding proteins, Ann. Rev. Microbiol., 45, 37, 10.1146/annurev.mi.45.100191.000345 Medeiros, 1997, Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics, Clin. Infect. Dis., 24, 19, 10.1093/clinids/24.Supplement_1.S19 Matthew, 1976, Analytical isoelectric focusing of R factor-determined β-lactamases: correlation with plasmid compatibility, J. Bacteriol., 125, 713, 10.1128/jb.125.2.713-718.1976 Dubois, 1995, TEM-and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function, J. Antimicrob. Chemother., 35, 7, 10.1093/jac/35.1.7 Philippon, 1989, Extended-spectrum β-lactamases, Antimicrob. Agents. Chemother., 33, 1131, 10.1128/AAC.33.8.1131 Perilli, 1997, Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain, Antimicrob. Agents. Chemother., 41, 2374, 10.1128/AAC.41.11.2374 Sirot, 1992, Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France, Antimicrob. Agents. Chemother., 36, 1677, 10.1128/AAC.36.8.1677 Sirot, 1997, A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate, Antimicrob. Agents. Chemother., 41, 1322, 10.1128/AAC.41.6.1322 Tzouvelekis, 1999, Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate, J. Clin. Microbiol., 37, 2388, 10.1128/JCM.37.7.2388-2388.1999 Thomson, 1999, Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp.Enterobacter spp Citrobacter freundii and Serratia marcescens, Antimicrob. Agents. Chemother., 43, 1393, 10.1128/AAC.43.6.1393 Prinarakis, 1997, Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant, Antimicrob. Agents. Chemother., 41, 838, 10.1128/AAC.41.4.838 Poyart, 1998, A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae, Antimicrob. Agents. Chemother., 42, 108, 10.1128/AAC.42.1.108 Jacoby, 1991, More extended-spectrum β-lactamases, Antimicrob. Agents. Chemother., 35, 1697, 10.1128/AAC.35.9.1697 Thomson, 1996, Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new β-lactam antibiotics, 151 Marchandin, 1999, TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient, Antimicrob. Agents. Chemother., 43, 2069, 10.1128/AAC.43.8.2069 Goussard, 1999, Updated sequence information for TEM beta-lactamase genes, Antimicrob. Agents. Chemother., 43, 367, 10.1128/AAC.43.2.367 Mugnier, 1996, A TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa, Antimicrob. Agents. Chemother., 40, 2488, 10.1128/AAC.40.11.2488 Nordmann, 1998, Extended-spectrum beta-lactamases in Pseudomonas aeruginosa, J. Antimicrob. Chemother., 42, 128, 10.1093/jac/42.2.128 Heritage, 1999, Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria, J. Antimicrob. Chemother., 44, 309, 10.1093/jac/44.3.309 Naas, 1999, Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa, FEMS Microbiol. Lett., 176, 411 Jarlier, 1988, Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns, Rev. Infect. Dis., 10, 867, 10.1093/clinids/10.4.867 Philippon, 1989, Epidemiology of extended spectrum β-lactamases, Infection, 17, 347, 10.1007/BF01650727 National Committee for Clinical Laboratory Standards, 1999, Performance standards for antimicrobial susceptibility testing; ninth informational supplement M100-S9, Wayne PA: National Committee for Clinical Laboratory Standards Jacoby, 1998, Epidemiology of extended-spectrum beta-lactamases, Clin. Infect. Dis., 27, 81, 10.1086/514644 Thomson, 1997, A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM-and SHV-derived extended-spectrum β-lactamases, Clin. Microbiol. Infect., 3, 549, 10.1111/j.1469-0691.1997.tb00306.x Coudron, 1997, Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a Veterans Medical Center: seek and you may find, J. Clin. Microbiol., 35, 2593, 10.1128/jcm.35.10.2593-2597.1997 Xiang, 1997, Mechanism and stability of hyperproduction of the extended-spectrum beta-lactamase SHV-5 in Klebsiella pneumoniae, J. Antimicrob. Chemother., 40, 525, 10.1093/jac/40.4.525 Brun-Buisson, 1987, Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbread of multiresistant Klebsiella pneumoniae, Lancet, ii, 302, 10.1016/S0140-6736(87)90891-9 Thomson, 1992, Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests, Antimicrob. Agents. Chemother., 36, 1877, 10.1128/AAC.36.9.1877 Fournier, 1996, Chromosomal β-lactamase genes of Klebsiella oxytoca are divided into two main groups, bla (OXY-1) and bla (OXY-2), Antimicrob. Agents. Chemother., 40, 454, 10.1128/AAC.40.2.454 Sirot, 1998, Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca, Antimicrob. Agents. Chemother., 42, 2184, 10.1128/AAC.42.9.2184 Gazouli, 1998, Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4) involvement of serine 237 in cephalosporin hydrolysis, Antimicrob. Agents. Chemother., 42, 1259, 10.1128/AAC.42.5.1259 Bradford, 1998, CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia, Antimicrob. Agents. Chemother., 42, 1980, 10.1128/AAC.42.8.1980 Gniadkowski, 1998, Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme, Antimicrob. Agents. Chemother., 42, 827, 10.1128/AAC.42.4.827 Wu, 1992, Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family, J. Antimicrob. Chemother., 30, 3, 10.1093/jac/30.1.3 Matsumoto, 1988, Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins, Antimicrob. Agents. Chemother., 32, 1243, 10.1128/AAC.32.8.1243 Watanabe, 1991, In vitro and in vivo transferrable beta-lactam resistance due to a new plasmid-mediated oxyiminocephalosporinase from a clinical isolate of Proteus mirabilis, Microbiol. Immunol., 35, 87, 10.1111/j.1348-0421.1991.tb01537.x Palucha, 1999, Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital, J. Antimicrob. Chemother., 44, 489, 10.1093/jac/44.4.489 Bernard, 1992, A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM-or SHV-type enzymes, J. Antimicrob. Chemother., 29, 590, 10.1093/jac/29.5.590 Ma, 1998, Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam, Antimicrob. Agents. Chemother., 42, 1181, 10.1128/AAC.42.5.1181 Danel, 1995, Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa, J. Antimicrob. Chemother., 35, 281, 10.1093/jac/35.2.281 Vahaboglu, 1998, Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter sp, J. Antimicrob. Chemother., 42, 269, 10.1093/jac/42.2.269 Mimoz, 1999, Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa, J. Antimicrob. Chemother., 44, 91, 10.1093/jac/44.1.91 Bauernfeind, 1996, Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase, Antimicrob. Agents. Chemother., 40, 260, 10.1128/AAC.40.3.616 Nordmann, 1993, Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa, Antimicrob. Agents. Chemother., 37, 962, 10.1128/AAC.37.5.962 Rossolini, 1999, Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene blaA (CME) encoding an extended-spectrum class A beta-lactamase related to the bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases, Antimicrob. Agents. Chemother., 43, 2193, 10.1128/AAC.43.9.2193 Philippon, 1997, OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa, Antimicrob. Agents. Chemother., 41, 2188, 10.1128/AAC.41.10.2188 Danel, 1999, Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa, J. Antimicrob. Chemother., 43, 339, 10.1093/jac/43.3.339 Mugnier, 1998, Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro, Antimicrob. Agents. Chemother., 42, 3113, 10.1128/AAC.42.12.3113 Henquell, 1994, Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in France, J. Antimicrob. Chemother., 34, 707, 10.1093/jac/34.5.707 Chaibi, 1999, Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics, J. Antimicrob. Chemother., 43, 447, 10.1093/jac/43.4.447 Sanders, 1992, β-lactam resistance in gram-negative bacteria: global trends and clinical impact, Clin. Infect. Dis., 15, 824, 10.1093/clind/15.5.824 Livermore, 1995, β-lactamases in laboratory and clinical resistance, Clin. Microbiol. Rev., 8, 557, 10.1128/CMR.8.4.557 Philippon, 1994, Origin and impact of plasmid-mediated extended-spectrum beta-lactamases, Eur. J. Clin. Microbiol. Infect. Dis., 13, 17, 10.1007/BF02390681 Papanicolaou, 1990, Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino-and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae, Antimicrob. Agents. Chemother., 34, 2200, 10.1128/AAC.34.11.2200 Bauernfeind, 1989, Extended broad-spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins, Infection, 17, 316, 10.1007/BF01650718 Bauernfeind, 1998, Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?, Yonsei Med. J., 39, 520, 10.3349/ymj.1998.39.6.520 Barnaud, 1998, Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii, Antimicrob. Agents. Chemother., 42, 2352, 10.1128/AAC.42.9.2352 Bauernfeind, 1999, A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia, Antimicrob. Agents. Chemother., 43, 1924, 10.1128/AAC.43.8.1924 Rasmussen, 1997, Carbapenem-hydrolyzing beta-lactamases, Antimicrob. Agents. Chemother., 41, 223, 10.1128/AAC.41.2.223 Paton, 1993, ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii, Int. J. Antimicrob. Agents., 2, 81, 10.1016/0924-8579(93)90045-7 Donald, 2000, Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92, Antimicrob. Agents. Chemother., 44, 196, 10.1128/AAC.44.1.196-199.2000 Livermore, 1997, Acquired carbapenemases, J. Antimicrob. Chemother., 39, 673, 10.1093/jac/39.6.673 Laraki, 1999, Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli, Antimicrob. Agents. Chemother., 43, 902, 10.1128/AAC.43.4.902 Kurokawa, 1999, Worldwide proliferation of carbapenem-resistant gram-negative bacteria, Lancet, 354, 955, 10.1016/S0140-6736(05)75707-X O′Hara, 1998, Novel metallo β-lactamase mediated by a Shigella flexneri plasmid, FEMS Microbiol. Lett., 162, 201 Blahova, 1994, Resistance to and hydrolysis of imipenem in nosocomial strains of Flavobacterium meningosepticum, Eur. J. Clin. Microbiol. Infect. Dis., 13, 833, 10.1007/BF02111348 Blahova, 1997, Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum, Eur. J. Clin. Microbiol. Infect. Dis., 16, 178, 10.1007/BF01709484 Koh, 1999, Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore, Lancet, 353, 2162, 10.1016/S0140-6736(05)75604-X Cardoso, 1999, Carbapenem-hydrolysing beta-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal, J. Antimicrob. Chemother., 44, 135, 10.1093/jac/44.1.135 Lauretti, 1999, Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate, Antimicrob. Agents. Chemother., 43, 1584, 10.1128/AAC.43.7.1584 Arakawa, 2000, Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds, J. Clin. Microbiol., 38, 40, 10.1128/JCM.38.1.40-43.2000 Mainardi, 1997, Carbapenem resistance in a clinical isolate of Citrobacter freundii, Antimicrob. Agents. Chemother., 41, 2352, 10.1128/AAC.41.11.2352 Bradford, 1997, Bush, Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein, Antimicrob. Agents. Chemother., 41, 563, 10.1128/AAC.41.3.563 Afzal-Shah, 1999, Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina, J. Antimicrob. Chemother., 43, 127, 10.1093/jac/43.1.127 Brown, 1998, Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2, Lancet, 351, 186, 10.1016/S0140-6736(05)78210-6 Stunt, 1998, The production of a novel carbapenem-hydrolysing beta-lactamase in Aeromonas veronii biovar sobria, and its association with imipenem resistance, J. Antimicrob. Chemother., 42, 835, 10.1093/jac/42.6.835